Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GCH Technology is a leading specialty chemicals company based in Guangzhou, China, that specializes in the research, development, and manufacture of high-performance polymer material additives. The company's core product portfolio includes nucleating agents, synthetic hydrotalcites, and composite additives, which are essential for producing high-performance resins and modified plastics. While primarily a materials science firm, GCH Technology is deeply integrated into the healthcare sector, providing specialized additives for medical equipment, pharmaceutical packaging, and food contact materials that meet stringent global safety standards. The company is recognized as a national-level "Little Giant" enterprise in China and was the first Chinese company to receive FDA certification for food contact material additives. Its ongoing research into layered double hydroxides (LDHs) also explores advanced applications in controlled-release drug delivery systems and biomedical coatings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GCH Technology.